The SARS-CoV2 pandemic has ignited a massive effort across the globe, led by medical researchers and biotech companies, to come up with therapies that can help patients and bring an end to the pandemic. Vaccines, antibodies, immunity and convalescent plasma have all become common medical terms used in households across the country.
However, what we haven't heard much about in the main stream media may be one of the most promising therapies to get COVID-19 patients off a ventilator. That "below the radar" therapy is the use of allogeneic off-the-shelf stem cell therapies that have